6838
台新藥
-0.30 (-1.26%)23.6090成交張數–本益比2.60股價淨值比0.00%殖利率2026-09-11資料日期
月營收
柱為單月營收(億元),線為年增率;近十年
| 月份 | 營收(億) | 月增 | 年增 | 去年同月(億) | 累計營收(億) | 累計年增 |
|---|---|---|---|---|---|---|
| 2026/08 | 0.00 | – | – | 0.00 | 0.48 | 804.2% |
| 2026/07 | 0.00 | -100.0% | – | 0.00 | 0.48 | 804.2% |
| 2026/06 | 0.01 | -71.1% | – | 0.00 | 0.48 | 804.2% |
| 2026/05 | 0.02 | – | -50.7% | 0.05 | 0.48 | 791.6% |
| 2026/04 | 0.00 | -100.0% | – | 0.00 | 0.45 | 7546.8% |
| 2026/03 | 0.44 | 3272.6% | – | 0.00 | 0.45 | 7546.8% |
| 2026/02 | 0.01 | – | 120.2% | 0.01 | 0.01 | 120.2% |
| 2026/01 | 0.00 | -100.0% | – | 0.00 | 0.00 | – |
| 2025/12 | 0.03 | – | – | 0.00 | 0.09 | -93.4% |
| 2025/11 | 0.00 | – | -100.0% | 0.02 | 0.06 | -95.6% |
| 2025/10 | 0.00 | -100.0% | -100.0% | 0.03 | 0.06 | -95.6% |
| 2025/09 | 0.01 | – | -79.0% | 0.04 | 0.06 | -95.4% |
| 2025/08 | 0.00 | – | – | 0.00 | 0.05 | -96.0% |
| 2025/07 | 0.00 | – | – | 0.00 | 0.05 | -96.0% |
| 2025/06 | 0.00 | -100.0% | -100.0% | 0.05 | 0.05 | -96.0% |
| 2025/05 | 0.05 | – | 734.3% | 0.01 | 0.05 | -95.8% |
| 2025/04 | 0.00 | – | – | 0.00 | 0.01 | -99.5% |
| 2025/03 | 0.00 | -100.0% | -100.0% | 1.28 | 0.01 | -99.5% |
| 2025/02 | 0.01 | – | – | 0.00 | 0.01 | – |
| 2025/01 | 0.00 | – | – | 0.00 | 0.00 | – |
| 2024/12 | 0.00 | -100.0% | – | 0.00 | 1.43 | 359.9% |
| 2024/11 | 0.02 | -31.0% | – | 0.00 | 1.43 | 359.9% |
| 2024/10 | 0.03 | -19.5% | – | 0.00 | 1.41 | 352.2% |
| 2024/09 | 0.04 | – | 656.2% | 0.01 | 1.37 | 341.0% |